Position in LYEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,163
-$622 QoQ
Shares Held
58
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026US BANCORP \DE\ holds $76,237,060 across 226 Biotechnology names. LYEL ranks #189 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
131,414 | $22,211,593 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,781 | $13,298,406 | |
| 3 | TECH |
BIO-TECHNE Corp
|
149,030 | $7,788,305 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,628 | $4,348,416 | |
| 5 | GMAB |
Genmab A/S
|
95,548 | $2,563,551 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,381 | $2,442,150 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,683 | $2,174,623 | |
| 8 | ARGX |
Argenx SE
|
2,823 | $2,061,495 |
All Filings in LYEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,163 | 58 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,785 | 58 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $941 | 58 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $512 | 58 | Shares | Defined | 2025-07-24 | |
| No filing history on record for this holder in this stock. | ||||||